Running a Marathon in Flip-Flops – Part 1: The Value of Incorporating Prerequisites into Process Validation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Running a Marathon in Flip-Flops – Part 1: The Value of Incorporating Prerequisites into Process Validation
Undertaking process validation involves a major commitment in terms of personnel, resources, time, and money. Performing prerequisite verifications can reduce the risk of making costly mistakes.


Pharmaceutical Technology


The Boston Marathon is one of the world's most prestigious racing events. It has distinguished itself from other races in many ways, one of which is the method of entry. Not only must each applicant meet a defined set of prerequisites in order to qualify as an entrant and compete in the race, but each entrant's qualifications are subject to verification prior to the race date. This qualification process coupled with the runner's own preparations for the race help to ensure that only experienced, capable, and well-trained athletes are competing on the streets of Boston on race day.

Just as the race entrant must meet a well defined set of race prerequisites, train adequately, and have the right equipment ready prior to the race, so too must a pharmaceutical or biopharmaceutical company meet a predefined set of prerequisites before embarking on the course towards process validation. This Part I article will focus on the value of incorporating prerequisites into a process validation protocol.

The quality systems approach to process validation

Developing a drug product is a lengthy process. Prior to commercial distribution, the US Food and Drug Administration requires that the manufacturing process for the product be validated. Process validation is defined as the accumulation of documented evidence that demonstrates with a high degree of assurance that a process can consistently meet its predetermined specifications and quality attributes. Not only does process validation satisfy regulatory requirements, it is good business practice to have the confidence that a manufacturing process is repeatable and will yield a quality product on a consistent basis.

Most companies understand the requirement for process validation. However, the way companies go about process validation oftentimes lacks the business-related benefits that may result from truly challenging the entire process.

Simply repeating the normal manufacturing process a series of times, collecting routine samples, and analyzing the samples for in-process and finished-product specifications is not sufficient to demonstrate that a process is validated. Performing validation in this manner only shows that at that particular date and time the technical aspects of the manufacturing process may or may not have been successful. In order to demonstrate repeatability, ensure a robust process after the process validation report is approved, and hence obtain a business-related benefit from the process validation activity, the quality systems contributing to the technical aspects of the process must be in a state of control. If these manufacturing support systems are not in control and sufficiently thorough, these so-called quality systems cannot be counted on to ensure the same process results. This is where the value of incorporating prerequisites comes into play.

Just as the marathon applicant must prove he or she meets the technical requirements to compete at the high standards the Boston Marathon requires, if accepted, the runner still makes sure to have eaten the right foods prior to the race and that his or her gear is in top condition and ready to go prior to starting the race. The same situation applies to the pharmaceutical or biopharmaceutical manufacturer during process validation. The company should prove that they have addressed and controlled all supporting process-related variables prior to starting the process validation production runs.

Process validation prerequisites 101

What are prerequsities? A prerequisite is defined within the context of this article as a documented verification in a process validation protocol, which, when met satisfactorily, is intended to demonstrate readiness for execution of a manufacturing run. A process that is not performed the same way every time cannot be considered validated. This is the core concept behind using prerequisite verifications during process validation. Any area that could lead to variation in a manufacturing process or in the analysis of the manufacturing process should be included in the prerequisite verifications section of the process validation protocol. The following is a brief description of the most common areas that should be verified, as these areas often lead to variation in the process.

Master batch record status verification.Using the example of the Boston Marathon runner, if the map has changed prior to the race and without notice, the runner may very well need a change of strategy and may even get to the intended destination without a considerable loss in valuable race time. The MBR is a road map for the manufacturing process. In this prerequisite, the effective version of the master batch record (MBR) is verified as the latest, approved version of the document and agrees with the version listed in the approved protocol.


ADVERTISEMENT

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
In light of the fact that most of the world is now out of the recession, how is your company faring compared with this time last year?
Better
Worse
About the same
Better
53%
Worse
27%
About the same
20%
View Results
Jim MillerOutsourcing OutlookJim Miller Time for a Model Upgrade
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Navigating the Global Pharmaceutical Supply Chain
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
FDA, Pharma, and Alliance Partner to Treat TB
Framing the argument
Pharma Companies and Suppliers Meet at DCAT Week
Biopharmaceutical Collaboration Is a Sign of the Times
Life After Big Pharma
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here